Williams Jones Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.45M Sell
33,917
-1,300
-4% -$223K 0.07% 128
2026
Q1
$5.95M Sell
35,217
-300
-0.8% -$51.3K 0.07% 123
2025
Q4
$5.99M Sell
35,517
-468
-1% -$76K 0.07% 123
2025
Q3
$5.2M Sell
35,985
-4,100
-10% -$560K 0.06% 133
2025
Q2
$5.07M Sell
40,085
-3,023
-7% -$371K 0.06% 131
2025
Q1
$5.51M Sell
43,108
-4,294
-9% -$582K 0.07% 129
2024
Q4
$6.27M Sell
47,402
-7,424
-14% -$1.04M 0.08% 126
2024
Q3
$7.98M Sell
54,826
-3,160
-5% -$457K 0.09% 120
2024
Q2
$7.96M Sell
57,986
-1,243
-2% -$166K 0.1% 114
2024
Q1
$8.13M Sell
59,229
-11,073
-16% -$1.51M 0.1% 113
2023
Q4
$9.55M Sell
70,302
-29,010
-29% -$3.54M 0.13% 104
2023
Q3
$12.1M Sell
99,312
-8,118
-8% -$1.03M 0.19% 85
2023
Q2
$13.6M Sell
107,430
-1,201
-1% -$156K 0.2% 80
2023
Q1
$14M Buy
108,631
+2,181
+2% +$285K 0.22% 82
2022
Q4
$14M Sell
106,450
-767
-0.7% -$99.1K 0.23% 80
2022
Q3
$12.5M Buy
107,217
+65
+0.1% +$8.07K 0.22% 84
2022
Q2
$12.6M Sell
107,152
-968
-0.9% -$115K 0.2% 87
2022
Q1
$14.1M Buy
108,120
+865
+0.8% +$113K 0.2% 83
2021
Q4
$16.4M Buy
107,255
+465
+0.4% +$72K 0.2% 80
2021
Q3
$17.3M Sell
106,790
-155
-0.1% -$26.1K 0.24% 77
2021
Q2
$17.5M Buy
106,945
+1,686
+2% +$260K 0.24% 76
2021
Q1
$15.8M Buy
105,259
+1,430
+1% +$227K 0.25% 76
2020
Q4
$15.7M Buy
103,829
+2,802
+3% +$400K 0.26% 70
2020
Q3
$13.7M Buy
101,027
+575
+0.6% +$78K 0.25% 72
2020
Q2
$13.7M Sell
100,452
-162
-0.2% -$20.7K 0.28% 67
2020
Q1
$10.8M Sell
100,614
-5,822
-5% -$670K 0.28% 64
2019
Q4
$12.8M Sell
106,436
-56,044
-34% -$6.25M 0.25% 77
2019
Q3
$16.2M Buy
+162,480
New +$17M 0.33% 66

Other funds holding IBB

Williams Jones Wealth Management's IBB Position: Q2 2026 in Review

Williams Jones Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 3.7% in Q2 2026, selling an estimated $223K and leaving 33,917 shares worth $6.45M. The position accounts for 0.07% of the portfolio, ranked #128.

Williams Jones Wealth Management first reported a position in IBB in Q3 2019 and has held it in 28 quarters since. The position peaked at $17.5M in Q2 2021. 523 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Williams Jones Wealth Management held 33,917 shares of iShares Biotechnology ETF worth $6.45M as of Q2 2026.
  • Williams Jones Wealth Management sold 1,300 iShares Biotechnology ETF shares in Q2 2026, an estimated $223K.
  • iShares Biotechnology ETF made up 0.07% of Williams Jones Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Williams Jones Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2019 and has held it in 28 quarters since.
  • Williams Jones Wealth Management's iShares Biotechnology ETF position peaked at $17.5M in Q2 2021.
  • 523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Williams Jones Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.